SCI时时刷

search
Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey
Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey
IntroductionStiff-person syndrome (SPS) is a rare autoimmune neurologic disorder characterized by progressive axial muscle...
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin {beta}7+ Compartment
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin {beta}7+ Compartment
AbstractBackground and Objectives Natalizumab, a monoclonal humanized antibody targeting integrin α4, inhibits the transmi...
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis
AbstractBackground and Objective In people with multiple sclerosis (pwMS), concern for potential disease exacerbation or t...
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes
AbstractBackground and Objectives To evaluate whether the kappa free light chain index (K-index) can predict the occurrenc...
SARS-CoV-2-Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19
SARS-CoV-2-Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19
AbstractBackground and Objectives Millions of Americans were exposed to SARS-CoV-2 early in the pandemic but could not get...
Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease
Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease
AbstractObjectives Anti-IgLON5 disease (IgLON5-D) may present with a bulbar-onset motor neuron disease-like phenotype, mim...
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
AbstractBackground and Objectives Patients with multiple sclerosis (PwMS) receiving extended dosing of rituximab (RTX) hav...
Electrolyte Imbalance in Anti-LGI1 Encephalitis: It Is Not All in Your Head
Electrolyte Imbalance in Anti-LGI1 Encephalitis: It Is Not All in Your Head
IntroductionAntileucine-rich glioma-inactivated-1 (LGI1) autoimmune encephalitis was first described in 20101,2 and is tod...
LGI1 Encephalitis and IgG4-Related Disease: Rare Conditions Collide
AbstractObjectives Leucine-rich glioma-inactivated 1 (LGI1) encephalitis and IgG4-related disease (IgG4RD) have traditiona...
Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria
IntroductionThe discovery of anti-NMDAR encephalitis (anti-NMDARE) in 2007 is regarded as a major breakthrough by introduc...
Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis
Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis
AbstractObjectives The objective of this study was to report on the development of neuroinvasive West Nile virus (WNV) inf...
Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
AbstractBackground and Objectives Neural antibodies are detected by tissue-based indirect immunofluorescence assay (IFA) i...
Unilateral Relapsing Primary CNS Vasculitis: Description of 3 Cases From a Single-Institutional Cohort of 216 Cases
Unilateral Relapsing Primary CNS Vasculitis: Description of 3 Cases From a Single-Institutional Cohort of 216 Cases
AbstractObjectives To define the frequency and characteristics of patients with unilateral relapsing involvement in a coho...
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
AbstractThe therapeutic success and widespread approval of genetically engineered T cells for a variety of hematologic mal...
Intrathecal CD8+CD20+ T Cells in Primary Progressive Multiple Sclerosis
Intrathecal CD8+CD20+ T Cells in Primary Progressive Multiple Sclerosis
AbstractBackground and Objective Despite accumulating evidence of intrathecal inflammation in patients with primary progre...
TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis
TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis
In most cases, multiple sclerosis (MS) begins as a relapsing-remitting disease (RRMS), but many patients proceed to second...